CBIO:NASDAQ
Crescent Biopharma Inc
US$13,52
arrow_downward
-0,37%(-0,050) 1D
7 ຕ.ລ., 15 ໂມງ 46 ນາທີ 43 ວິນາທີ GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CBIO...
Open
US$13,47
High
US$14,20
Low
US$13,26
Mkt. cap
503,67 ລ້ານ
Avg. vol.
463,73 ພັນ
Volume
910,91 ພັນ
52-wk high
US$27,41
52-wk low
US$8,72
EPS
US$-7,41
Beta
1,27
Shares outstanding
37,14 ລ້ານ
No. of employees
69
Open
US$13,47
High
US$14,20
Low
US$13,26
Mkt. cap
503,67 ລ້ານ
Avg. vol.
463,73 ພັນ
Volume
910,91 ພັນ
52-wk high
US$27,41
52-wk low
US$8,72
EPS
US$-7,41
Beta
1,27
Shares outstanding
37,14 ລ້ານ
No. of employees
69
News stories
From web sources and news partners
Stock Titan
·
23 ຊົ່ວໂມງກ່ອນ
Six employees can buy Crescent shares for $13.94 each once their options vest.
Investing.com
·
1 ມື້ກ່ອນ
Stifel reiterates Buy on Crescent Biopharma stock, $28 target
Investing.com
·
1 ມື້ກ່ອນ
Crescent Biopharma stock rating upgraded to buy at H.C. Wainwright
Stock Titan
·
2 ມື້ກ່ອນ
The FDA clears an application to test Crescent’s cancer treatment in people.
About Crescent Biopharma Inc
CEO-
Employees69
Founded2024
HeadquartersWaltham, ມາຊາຊູເຊັດ, ສະຫະລັດ
SectorBiotechnology
Websitecrescentbiopharma.com